DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Molecule Holdings Inc.

DB:ERV2 Stock Report

Market Cap: €330.8k

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Molecule Holdings Management

Management criteria checks 2/4

Molecule Holdings' CEO is David Reingold, appointed in Sep 2021, has a tenure of 2.75 years. directly owns 1.88% of the company’s shares, worth €6.22K. The average tenure of the management team and the board of directors is 2.6 years and 3.8 years respectively.

Key information

David Reingold

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.8yrs
CEO ownership1.9%
Management average tenure2.6yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has David Reingold's remuneration changed compared to Molecule Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Jul 31 2023n/an/a

-CA$3m

Apr 30 2023n/an/a

-CA$4m

Jan 31 2023n/an/a

-CA$4m

Oct 31 2022n/an/a

-CA$5m

Jul 31 2022n/an/a

-CA$4m

Apr 30 2022n/an/a

-CA$4m

Jan 31 2022n/an/a

-CA$5m

Oct 31 2021CA$91kCA$91k

-CA$4m

Jul 31 2021n/an/a

-CA$6m

Apr 30 2021n/an/a

-CA$5m

Jan 31 2021n/an/a

-CA$4m

Oct 31 2020CA$16kn/a

-CA$3m

Compensation vs Market: Insufficient data to establish whether David's total compensation is reasonable compared to companies of similar size in the German market.

Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.


CEO

David Reingold (62 yo)

2.8yrs
Tenure
CA$91,000
Compensation

Mr. David Reingold has been a President & Chief Executive Director & Director of Molecule Holdings Inc. since September 15, 2021 and served its as an Independent Director since September 16, 2020 until Sep...


Leadership Team

NamePositionTenureCompensationOwnership
Andre Audet
Co-Founder21.6yrsCA$26.00k9.7%
€ 32.1k
David Reingold
CEO, President & Director2.8yrsCA$91.00k1.88%
€ 6.2k
Amy Proulx
Co-Founder & Independent Directorno datano datano data
Philip Waddington
COO & Director2.8yrsCA$86.80kno data
Becky Griffin
Chief Innovation Officer2.4yrsno datano data
Tiago Zamponi
Head of Provincial Salesno datano datano data
2.6yrs
Average Tenure
62yo
Average Age

Experienced Management: ERV2's management team is considered experienced (2.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Andre Audet
Co-Founder21.6yrsCA$26.00k9.7%
€ 32.1k
David Reingold
CEO, President & Director3.8yrsCA$91.00k1.88%
€ 6.2k
Amy Proulx
Co-Founder & Independent Director3.8yrsno datano data
Philip Waddington
COO & Director3.8yrsCA$86.80kno data
Lindsay Weatherdon
Independent Director3.8yrsno datano data
3.8yrs
Average Tenure
61.5yo
Average Age

Experienced Board: ERV2's board of directors are considered experienced (3.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/06/02 15:58
End of Day Share Price 2024/03/06 00:00
Earnings2023/07/31
Annual Earnings2022/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Molecule Holdings Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide